A Rare Virus, a Cruise Ship, and Three People in King County: Inside the Hantavirus Scare That WHO Says Won't Become a Pandemic

On April 1, 2026, the MV Hondius — a Dutch-flagged expedition cruise ship operated by Oceanwide Expeditions — departed Ushuaia, Argentina, carrying roughly 170 passengers bound for a South Atlantic wildlife voyage [1]. Six weeks later, three of those passengers were dead, eleven had confirmed or probable hantavirus infections, and health authorities across at least nine countries were tracing contacts and quarantining travelers [2]. Three residents of King County, Washington, found themselves caught in the expanding net of monitoring, raising alarm in a region already familiar with hantavirus — though a very different strain from the one now making headlines.

The World Health Organization says this is not the beginning of a pandemic. The CDC calls the risk to the American public "extremely low" [3]. But the outbreak has exposed a series of questions about cruise ship disease surveillance, the limits of public health messaging for ultra-rare pathogens, and what it means to be "possibly exposed" to a virus with no vaccine and no antiviral treatment.

The MV Hondius Outbreak: What Happened

The index case — the first person believed to have been infected — was a passenger who had engaged in birdwatching activities in Argentina, Chile, and Uruguay before boarding the MV Hondius [2]. Hantaviruses are carried by rodents, and the Andes virus specifically circulates among long-tailed pygmy rice rats (Oligoryzomys longicaudatus) in southern South America. Exposure likely occurred through inhalation of aerosolized rodent droppings or urine during outdoor excursions ashore [4].

The passenger fell ill and died aboard the ship on April 11 [1]. His body was taken ashore at the island of Saint Helena on April 24. His wife disembarked there as well, was evacuated to Johannesburg, and died in a hospital two days later [1]. A third death followed, bringing the total to three fatalities out of what WHO reported as eight cases (six confirmed, two probable) by May 8, with the count rising to eleven confirmed and probable cases by May 12 [2][5].

Source: WHO Disease Outbreak News

Data as of May 12, 2026CSV

The case fatality ratio within this cluster stands at roughly 27% (three deaths among eleven cases), which is below the historical U.S. average of 35% for hantavirus pulmonary syndrome (HPS) but within the broader range seen in the Americas, where case fatality rates for HPS have been documented at 25–50% depending on the strain and the speed of medical intervention [6][7].

The Virus: Andes Hantavirus and Why It Matters

The pathogen responsible is Andes virus, a New World hantavirus that causes hantavirus cardiopulmonary syndrome (HCPS) — a severe illness characterized by fever, muscle aches, and rapidly progressing respiratory failure [4]. What distinguishes Andes virus from nearly every other hantavirus on earth is its capacity for limited person-to-person transmission [8].

This is a critical distinction. The Sin Nombre virus responsible for most U.S. hantavirus cases spreads exclusively from rodents to humans. Andes virus can, in rare circumstances, pass between people — but the transmission requires prolonged close contact, particularly among household members, intimate partners, or healthcare workers providing direct care [4][8]. WHO spokesperson Christian Lindmeier stated plainly: "This is not COVID" and emphasized that "it's not spreading anything close to how COVID was spreading" [9].

Decades of experience in South America reinforce this. Argentina has documented multiple Andes virus clusters since the late 1990s, including a well-studied 2018–2019 outbreak in Epuyén, Patagonia, where person-to-person transmission was confirmed among close contacts. Even in that cluster, transmission chains were short and self-limiting [8].

Three King County Residents: What "Possibly Exposed" Means

The Washington State connection centers on three King County residents identified by public health officials in early May [10].

Two of them were never aboard the MV Hondius. They were seated on an airplane near an ill cruise ship passenger who was removed from the aircraft before takeoff and later tested positive for Andes virus [10]. The third King County resident was a passenger on the cruise ship itself and was transferred to the University of Nebraska Medical Center's National Quarantine Unit — the only federal biocontainment facility of its kind in the United States [11].

As of mid-May, all three were asymptomatic [10]. Dr. Sandra Valenciano, a King County health officer, stated that "we have strong contact tracing and monitoring in place" and that "the risk of this virus spreading to residents of King County is low at this time" [10].

The term "possibly exposed" has a specific public health definition in this context. It means an individual had sufficient proximity to a confirmed or suspected case that transmission cannot be ruled out, but no infection has been detected [10]. For Andes virus, the monitoring protocol requires 42 days of daily temperature checks and symptom surveillance after the last potential exposure [12]. Symptoms that would trigger immediate medical evaluation include fever above 101°F, severe muscle aches, headache, and — most critically — any signs of respiratory distress such as cough or shortness of breath [4][12].

If a monitored individual develops symptoms consistent with HPS, they would be tested via RT-PCR and serological assays for Andes virus antibodies. Only a positive laboratory result converts a "possible exposure" into a "confirmed case" [12].

The WHO's Risk Assessment — and Its Limits

WHO's formal risk assessment, issued May 8, classified the risk as moderate within the ship environment and low at the global population level [2]. The agency cited several factors supporting this determination: the requirement for prolonged close contact for person-to-person transmission; the rapid isolation of symptomatic cases once identified; active contact tracing across all countries with repatriated passengers; and the historical pattern of short, self-limiting transmission chains for Andes virus [2].

The epidemiological logic is sound on its own terms. Hantaviruses do not spread through casual contact, respiratory droplets in the manner of influenza, or fomites (contaminated surfaces). The basic reproduction number (R₀) for Andes virus person-to-person transmission has never been estimated above 1.0 in any documented outbreak, meaning each case generates fewer than one secondary case on average — a mathematical guarantee of eventual extinction of any transmission chain [8].

But critics of the "low risk" framing point to two vulnerabilities. First, the 42-day incubation period means that passengers who were repatriated to their home countries in early May could still develop symptoms well into June [12]. Second, the thresholds WHO uses for risk assessment were developed primarily from terrestrial Andes virus outbreaks in rural South America, not from a confined-space exposure on a cruise ship carrying elderly passengers (average age 65) with extended shared living quarters [2]. Whether those thresholds transfer directly to a maritime setting has not been independently validated.

Still, the available evidence to date supports WHO's assessment. No secondary cases have been reported among contacts who were not aboard the MV Hondius. A flight attendant who handled an infected passenger tested negative. Even cabin-mates of confirmed cases did not consistently become infected [9].

Hantavirus in the United States: A Rare but Persistent Threat

To understand the MV Hondius outbreak in context, consider the baseline. Since surveillance began in 1993, the CDC has recorded 890 laboratory-confirmed cases of hantavirus disease in the United States through the end of 2023 — fewer than 30 per year on average [6]. The 35% overall case fatality rate makes it one of the deadliest infectious diseases in the country on a per-case basis, but its rarity means it claims far fewer lives annually than influenza, COVID-19, or even rabies [6].

Source: CDC Reported Cases of Hantavirus Disease

Data as of Jan 1, 2024CSV

Annual case counts have fluctuated between 15 and 38 over the past decade, with 2016 recording the highest count (38 cases) and 2021 the lowest (15 cases) [6]. In 2025, the United States reported seven confirmed cases and two deaths across five states: Arizona (3), Colorado (1), Nevada (1), Washington (1), and Wisconsin (1) [13].

Source: CDC Reported Cases of Hantavirus Disease

Data as of Jan 1, 2024CSV

Ninety-four percent of all U.S. hantavirus cases have occurred west of the Mississippi River [6]. New Mexico (122 cases), Colorado (119), and Arizona (86) lead the cumulative count. Washington State ranks fifth nationally with 50 cases over three decades [6]. The predominant U.S. strain is Sin Nombre virus, carried by deer mice (Peromyscus maniculatus), which does not transmit between humans [14].

The MV Hondius cluster represents a genuinely novel exposure scenario for Washington State — and for the United States broadly. U.S. hantavirus cases have historically been linked to rural and peridomestic rodent exposure: cleaning out cabins, sheds, or barns; sleeping in rodent-infested structures; agricultural work [6]. A cruise ship–linked cluster involving a South American strain with person-to-person transmission potential is without precedent in U.S. surveillance records.

Rodent Reservoirs in the Pacific Northwest

King County's local hantavirus risk is distinct from the cruise ship outbreak. The region harbors Sin Nombre virus in deer mice populations, and since 1997, six hantavirus cases have been reported in King County [14]. Deer mice in the Pacific Northwest nest in homes, garages, outbuildings, and sheds, most commonly in wooded rural and suburban settings [14].

A 2025 study published in Ecosphere examined environmental factors influencing hantavirus distribution in U.S. rodent populations and found that warmer winters and increased precipitation can drive higher rodent population densities, while drier conditions facilitate the aerosolization of contaminated dust — the primary transmission route for Sin Nombre virus [13]. However, no federal or state wildlife agency has published data indicating unusually elevated hantavirus prevalence in Pacific Northwest rodent populations in 2025 or 2026. Washington State typically reports roughly two hantavirus cases per year [15].

No Vaccine, No Antiviral: The Honest Risk Calculus

There is no licensed vaccine for any hantavirus and no approved antiviral treatment for hantavirus pulmonary syndrome [4][16]. Ribavirin, an antiviral that has shown efficacy against hantavirus hemorrhagic fever with renal syndrome (the Old World form of the disease), has not demonstrated effectiveness for HPS and is not approved for either treatment or prophylaxis [4].

Treatment is entirely supportive: mechanical ventilation, hemodynamic support, and — in severe cases — extracorporeal membrane oxygenation (ECMO). Early transfer to an intensive care unit with ECMO capability is the single most important factor in survival [4].

For passengers who were aboard the MV Hondius, the risk calculus depends on their exposure profile. Those who had prolonged close contact with symptomatic cases — sharing cabins, providing care, or spending extended time in enclosed spaces with infected individuals — face the highest risk and are being actively monitored under CDC and WHO protocols [12]. Those who were aboard the ship but had no identifiable close contact with symptomatic passengers face a lower but non-zero risk, given the confined nature of cruise ship common areas [2].

For the two King County residents who sat near an infected passenger on an airplane, the risk is lower still. Airplane exposure is brief and typically does not meet the threshold of "prolonged close contact" that epidemiological studies associate with Andes virus transmission [10].

Moderna and Korea University's Vaccine Innovation Center have been collaborating on an mRNA-based Andes virus vaccine since 2023. Preclinical results published in 2025 showed the vaccine prevented infection in mice, but human trials have not yet been funded [16][17]. No finished vaccine is expected in the near term.

Cruise Ship Liability and Disclosure

The MV Hondius outbreak has renewed scrutiny of cruise ship health reporting obligations. Under U.S. maritime law, cruise operators are required to exercise "reasonable care under the circumstances," which includes isolating sick passengers, implementing sanitation measures, and communicating health risks to travelers [18]. The CDC's Vessel Sanitation Program monitors illness outbreaks on ships using U.S. ports and conducts inspections covering sanitation, food safety, water quality, and medical procedures [18].

However, maritime attorney Jack Hickey noted that specific regulatory guidelines for how cruise lines must handle infectious disease outbreaks remain vague. "The answer is, it's reasonable to do all three" — masking requirements, passenger communication, and quarantine — but none is explicitly mandated by regulation [18]. Hantavirus disease is a nationally notifiable condition in the United States, meaning confirmed cases must be reported to public health authorities, but the reporting obligations for the cruise operator itself are less clearly defined [18].

Oceanwide Expeditions, the operator of the MV Hondius, published a timeline of the medical situation aboard the vessel and cooperated with Spanish authorities when the ship docked in Tenerife on May 10 for passenger disembarkation and medical evacuation [1]. Passengers were repatriated on evacuation flights to six European countries and Canada, with American passengers transferred to the Nebraska Biocontainment Unit and Emory University Hospital in Atlanta [3][11].

The Cruise Lines International Association defended industry health protocols, stating that member lines maintain "comprehensive health, sanitation, and medical protocols" [18]. Whether those protocols were sufficient to detect and respond to the initial hantavirus cases aboard the MV Hondius — a ship that sailed for more than five weeks after the index case's death before the outbreak was formally reported to WHO — remains an open question.

What Comes Next

The 42-day monitoring window for MV Hondius passengers extends into mid-June 2026. Until that window closes without new cases, the outbreak cannot be declared over [12]. Spain has ordered a 42-day quarantine for passengers who disembarked in Tenerife [19]. American passengers remain at federal biocontainment and quarantine facilities.

The CDC has issued interim guidance for Andes virus public health investigations, and state health departments in every state to which passengers returned are conducting active surveillance [3]. To date, no confirmed cases of Andes virus have been identified in the United States as a result of this outbreak [3].

The public health messaging has walked a careful line: firm enough to ensure compliance with monitoring protocols among exposed individuals, measured enough to avoid triggering panic about a virus that, by every historical measure, does not sustain community transmission. Whether that calibration holds will depend on what happens in the weeks ahead — and on whether the distinction between a contained cluster and a spreading outbreak remains as clear as WHO currently believes it to be.